Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Rachael L. Sumner

A Randomised, Double-Blind, Active Placebo-Controlled, Parallel Groups, Dose-Response Study of Scopolamine Hydrobromide (4–6 Μg/Kg) in Patients With Major Depressive Disorder

Trials

Medicine

Pharmacology

2020

English

Related publications

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Lisdexamfetamine Dimesylate Augmentation for Major Depressive Disorder in Adults With Inadequate Response to Antidepressant Therapy

Journal of Psychopharmacology

English

A Randomized, Double-Blind, Placebo-Controlled Study of Flexible Doses of Levomilnacipran ER (40–120 Mg/Day) in Patients With Major Depressive Disorder

Journal of Drug Assessment

2014

English

Curcumin for the Treatment of Major Depression: A Randomised, Double-Blind, Placebo Controlled Study

Journal of Affective Disorders

English

Randomised, Double-Blind, Placebo-Controlled Study of Olanzapine in Patients With Bipolar I Depression

British Journal of Psychiatry

English

Memantine Treatment in Patients With Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study

Journal of Alzheimer's Disease

English

A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder

Journal of Clinical Psychiatry

English

Escitalopram and Paroxetine in the Treatment of Generalised Anxiety Disorder: Randomised, Placebo-Controlled, Double-Blind Study

British Journal of Psychiatry

English

A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients

BMC Musculoskeletal Disorders

English

Modified-Release Prednisone for Polymyalgia Rheumatica: A Multicentre, Randomised, Active-Controlled, Double-Blind, Parallel-Group Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Rachael L. Sumner

A Randomised, Double-Blind, Active Placebo-Controlled, Parallel Groups, Dose-Response Study of Scopolamine Hydrobromide (4–6 Μg/Kg) in Patients With Major Depressive Disorder

Related publications

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Lisdexamfetamine Dimesylate Augmentation for Major Depressive Disorder in Adults With Inadequate Response to Antidepressant Therapy

A Randomized, Double-Blind, Placebo-Controlled Study of Flexible Doses of Levomilnacipran ER (40–120 Mg/Day) in Patients With Major Depressive Disorder

Curcumin for the Treatment of Major Depression: A Randomised, Double-Blind, Placebo Controlled Study

Randomised, Double-Blind, Placebo-Controlled Study of Olanzapine in Patients With Bipolar I Depression

Memantine Treatment in Patients With Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study

A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder

Escitalopram and Paroxetine in the Treatment of Generalised Anxiety Disorder: Randomised, Placebo-Controlled, Double-Blind Study

A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients

Modified-Release Prednisone for Polymyalgia Rheumatica: A Multicentre, Randomised, Active-Controlled, Double-Blind, Parallel-Group Study